Entity Details

Primary name SPRE_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP35270
EntryNameSPRE_HUMAN
FullNameSepiapterin reductase
TaxID9606
Evidenceevidence at protein level
Length261
SequenceStatuscomplete
DateCreated1994-02-01
DateModified2021-06-02

Ontological Relatives

GenesSPR

GO terms

Show/Hide Table
GOName
GO:0004033 aldo-keto reductase (NADP) activity
GO:0004757 sepiapterin reductase activity
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0006729 tetrahydrobiopterin biosynthetic process
GO:0006809 nitric oxide biosynthetic process
GO:0046146 tetrahydrobiopterin metabolic process
GO:0050661 NADP binding
GO:0050999 regulation of nitric-oxide synthase activity
GO:0070062 extracellular exosome

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR002347 Short-chain dehydrogenase/reductase SDRFamilyFamily
IPR006393 Sepiapterin reductaseFamilyFamily
IPR036291 NAD(P)-binding domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612716 OMIMDystonia, DOPA-responsive, due to sepiapterin reductase deficiency (DRDSPRD)A form of DOPA-responsive dystonia. In the majority of cases, patients manifest progressive psychomotor retardation, dystonia and spasticity. Cognitive anomalies are also often present. The disease is due to severe dopamine and serotonin deficiencies in the central nervous system caused by a defect in BH4 synthesis. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB02637 Oxaloacetate IonDrugbanksmall molecule
DB03461 Nicotinamide adenine dinucleotide phosphateDrugbanksmall molecule
DB03886 BiopterinDrugbanksmall molecule
DB04275 N-acetylserotoninDrugbanksmall molecule

Interactions

3 interactions